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Mass spectrometrical sequence determination of the 
single peptides in mixtures of synthetic peptides [ 1,2] 
and of protein-derived peptides [3,4] has been 
reported. Exact mass determination and metastahle 
ion data have been used for the interpretation [I]. Also 
low resolution mass spectrometry of permethylated 
peptide mixtures combined with partial vaporization 
[2,4] and knowledge of the amino acid composition 
of the mixture have been applied [2]. The techniques 
described above may, however, not always provide 
sufficient information in order to obtain a correct 
interpretation of the mass spectra of peptide mixtures. 
Techniques for obtaining additional information are 
therefore required. 
The interpretation of mass spectra of peptides and 
peptide mixtures is mostly carried out by matching 
numerical mass differences between peaks with the 
integral masses of different derivatized amino acid 
residues. For a list of the permethylated amino acid 
residues see [4] . However, considering only the 
sequence peaks, it can be foreseen that several possibili- 
ties for ambiguities exist when dealing with peptide 
mixtures. Some examples are presented in table 1. 
The alternative sequences in group A and B in table 
1 are identical in elementary composition with the 
correct sequences and thus cannot be eliminated by 
high resolution mass spectrometry. On the other hand 
high resolution measurements would eliminate the 
alternative sequences in group C and D. The ambigui- 
ties in group A, C and D, however, depend on the 
Table 1 
Examples of ambiguities in mass spectrometry of permethyl- 
ated peptide mixtures. 
__- ______~___ 
Actual sequence Alternative sequence 
A) -MeGly-MeLeu- 
-MeAla-MeVal- 
-MeGly-MeVal- 
-MeAla-MeAla - 
-MeAIa-MeCly- 
B) Ac-MeLeu-MeAla- 
Ac-MeAla- 
Ac-MeGly -MeaGlu- 
Ac-MeAla- 
C) -MeAla-MeaTh- 
D) Ac-MeLeu-MeMet- 
Ac-MeaAsp- 
-e-Ac-MeaLys- 
-c-Ac-MeaLys- 
-G-Ac-MeaOrn- 
-MesGln- 
-MesAsn- 
Ac-MeAla-MeLeu 
Ac-MeAla-MeaAsp- 
-MeaTry- 
Ac-MeaAsp-MeaThr- 
--------~ -___ -__- 
When the sequences in the fist column are present, the 
sequences in the second column are also deduced. 
derivatives used. The present experiments demonstrate 
that alternative sequences, as shown in group A, C and 
D, can be eliminated by comparing the sequences 
deduced from the spectra of the acetylated and per- 
methylated mixture with those deduced from the 
spectra of the deuteroacetylated and deuteroper- 
,methylated mixture. Simultaneously, most of the 
alternative sequences due to non-sequence peaks are 
eliminated. 
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2. Experimental 
Two mixtures of synthetic peptide derivatives were 
used in the experiments: 
*I Boc-Ala-Pro-Leu-Phe-Val-Gly-OMe 1.40 rngh 1.9 pmole 
H-Asp-Glu-Ala-Asp-Pro-OH 1.05 mgz, 1.9 pmole 
II Z-Leu-Val-Glu(OBut)-Ala-OMe 0.77 mg% 1.2 pmole 
Z-Gly-Pro-Ala-Thr-OME 0.56 mg% 1.2 pmole 
The peptides in 1 are synthesized by the solid phase 
technique and the peptides in II in solution. 
Removal of the Boc group was carried out by treat- 
ment with 0.5 ml trifluoroacetic acid for 30 min at 
room temp. The trifluoroacetic acid was removed by 
evaporation. Removal of the benzyloxycarbonyl group 
and the t-butylester group was carried out as previously 
described [2]. After removal of the protecting groups 
the mixtures were dissolved in 1 ml of methanol. Half 
of each mixture, a, was acetylated by addition of 0.2 
ml acetic anhydride; the other half, b, was deutero- 
acetylated by the addition of 0.2 ml hexadeuteroacetic 
anhydride (Merck, Darmstadt). After reaction for 1 hr 
at room temp the samples were evaporated to dryness. 
The acetylated mixtures, a, were permethylated with 
methyliodide, using sodiumhydride/dimethylsulfoxide 
as base [ 5,6] , and the deuteroacetylated mixtures, b, 
deuteropermethylated with trideuteromethyliodide 
(Merck, Darmstadt). 
In order to investigate whether the C-terminal 
methylester was quantitatively transesterified during 
deuteropermethylation, CD,CO-Ser-Glu-Pro-Ala-OMe 
was deuteropermethylated. A molecular peak at m/e 
460 corresponding to the deuteromethylester was 
found and no peak at m/e 457. This peptide was 
chosen for the experiment because the C-terminal ions 
(Hz -Pro-Me-da-OMe) and (I-I, -MeGly-Pro-MeAla- 
Ome) give rather intense peaks, allowing a con- 
firmation of the quantitative transesterification. 
A Perkin-Elmer 270 mass spectrometer operating at 
70 eV was used. The resolution was approx. 1000. The 
samples were introduced directly into the ion source 
(temp 150”) and the solids inlet probe was slowly 
heated from 70” to 200”. During this period spectra 
were recorded at regular intervals. 
* Abbreviations: Boc: t-butyloxycarbonyl; Z: Benzyloxy- 
carbonyl; OBut: y-t-butylester. 
3. Results 
3.1. Peptide mixture I 
Analysis of the intensities of the sequence peaks in 
the spectra obtained at different temperatures howed 
that no noticeable partial vaporization had taken place. 
The intensities of the sequence peaks normally 
decrease with a factor of 2-10 from one sequence 
peak to the next at higher mass [7] . In order to 
compensate for the decrease, a stepwise increasing 
amplification was used. In all amplifications applied, 
peaks higher than 5% of the base peak were considered 
during the interpretation. It is thus not a relative in- 
tensity understood in the usual way, but a false relative 
intensity, where a correction for the decrease was 
aimed at. The interpretation was carried out by locating 
peaks possibly corresponding to N-terminal acyl amino 
acid residues. From these peaks, sequences were 
deduced by trial and error. The results are shown in 
table 2. 
The sequences common for the 2 derivatives are 
in italics. It is observed that the comparison, in spite 
of the large number of possibilities, in this case leads 
to the determination of the correct sequences. 
3.2. Peptide mtiture II 
In this experiment the partial vaporization was also 
negligible. Analysis of the spectra resulted in a list of 
possible sequences very similar to table 2. Comparison 
of the results obtained with the 2 derivatives reduced 
the number of possible sequences to those listed in 
table 3. It is seen that more sequences are still possible 
on the tetrapeptide level and additional information 
must be used in order to obtain an unambiguous inter- 
pretation. 
In the present example, knowledge of the amino 
acid composition confirms L.eu-Val-Glu-Ala and 
Gly-Pro-Ala-Thr as the correct sequences. The 2 
sequences are also the only ones in table 3 where a 
termination of the sequence was found. For the first 
sequence the molecular ion was present and for the 
second a peak corresponding to loss of methanol from 
the molecular ion. 
The sequence Leu-Val-Glu-Ser can also be elim- 
inated due to the lack of peaks corresponding to a loss 
of methanol from either the sequence ion or the mole- 
cular ion. The peaks on each side of the intense sequence 
peak of Leu-Val-Glu give rise to both Gly-Pro-Ala- 
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Table 2 
Possible sequences from peptide mixture Ia 
#$j 
i 2 ‘e 
AIa(128) Asp(l86) 
$ i$ Ala-Pro(225) Asp-Glu(343) 
Ala-Pro-Leu(352) 
Ala-Pro-Phe(386) 
Ala-Pro-Leu-Phe(513) 
Ala-Pro-Phe-Val(499) 
Ala-Pro-Phe-Leu(513) 
Ala-Pro-Phe-Om(570) 
Ala-Pro-Leu-Phe- Val(626) 
Ala-Pro-Leu-Phe-Ser (628) 
*Ala-Pro-Leu-Phe-Orn(697) 
Ala-Pro-Phe-Vat-Gly(570) 
Ala-Pro-Phe-Val-Leu(626) 
Ma-Pro-Phe-Val-Thr(628) 
Ala-Pro-Phe-Val-Lys(697) 
Ala-Pro-Phe-Val-Try (7 13) 
Ala-Pro-Phe-Leu-Val(626) 
Ala-Pro-Phe-Leu-Ser(628) 
Ala-Pro-Phe-Leu-Orn(697) 
Ala-Pro-Phearn-Leu(697) 
Ala-Pro-Phearn-Thr(699) 
Ala-Pro-Phearn-Asp(7 13) 
Asp-Glu-Ala(428) 
Asp-Glu-Asn(499) 
*Asp-Glu-Gln(513) 
Asp-Glu-Ala-Gly(499) 
*Asp-Glu-Ala-Ala(513) 
Asp-Glu-Ala-Pro(525) 
Asp-Glu -Ala-Asp(57 1) 
*Asp-Glu-Ala-Lys(626) 
Asp-Glu-AsnGly(570) 
Asp-Glu-Asn-Leu(626) 
Asp-Glu-Asn-Thr(628) 
Asp-Glu-Asn-Lys(697) 
Asp-Glu-Asn-Try(7 13) 
*Asp-Glu-GlnVal(626) 
Asp-Glu-Gln-Ser(628) 
*Asp-Glu-Gln-Orn(697) 
Asp-Glu-Ala-Gly-Gly(570) 
Asp-Glu-Ala-Gly-Leu(626) 
Asp-Glu-Ala-Gly-Thr(628) 
Asp-Glu-Ala-Gly-Lys(697) 
Asp-Glu-Ala-Gly-Try(713) 
*Asp-Glu-Ala-Ala-Val(626) 
Asp-Glu-Ala-Ala-Ser(628) 
Asp-Glu-Ala-Ala-Asn(669) 
*Asp-Glu-Ala-AlaCIrn(697) 
Asp-Glu-Ala-Pro-Asp(668) 
Asp-Glu-Ala-Asp-Pro(668) 
Asp-Glu-Ala-Asp-Leu(698) 
Asp-Glu-Ala-Asp-Thr(700) 
Asp-Glu-Ala-Asp-Asp(714) 
Asp-Glu-Ala-Asp-Glu(728) 
*Asp-Glu-Ala-Lys-Gly (697) 
Asp-Glu-Asn-Gly-Leu(697) 
Asp-Glu-Asn-Gly-Thr(699) 
Asp-Glu-Asn-Gly-Asp(713) 
Asp-Glu-Asn-Leu-Gly(697) 
Asp-Glu-Asn-Thr-Gly(699) 
Asp-Glu-Asn-Th-Ala(713) 
*Asp-Glu-Gln-Val-Gly(697) 
Asp-Glu-Gln-Ser-Gly(699) 
Asp-Glu-Gln-Ser-Ala(713) 
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Table 2 continued 
Ala-Pro-Leu-Phe- Val-Gly(697) 
Ala-Pro-Leu-Phe-Ser-Gly(699) 
Ala-Pro-Leu-Phe-Ser-Gly(713) 
Ala-Pro-Phe-Val-Gly-Leu(697) 
Ala-Pro-Phe-Val-Gly-Thr(699) 
Ala-Pro-Phe-Val-Gly-Asp(713) 
Ala-Pro-Phe-Val-Leu-Gly(697) 
Ala-Pro-Phe-Val-Thr-Gly(699) 
Ala-Pro-Phe-Val-Th-Ala(713) 
Ala-Pro-Phe-Leu-Val-Gly(697) 
Ala-Pro-Phe-Leu-Ser-Gly(699) 
Ala-Pro-Phe-Leu-Ser-Ala(713) 
Asp-Glu-Ala-Gly-Gly-Leu(697) 
Asp-Glu-Ala-Gly-Gly-Thr (699) 
Asp-Glu-Ala-Gly-Gly-Asp(713) 
Asp-Glu-Ala-Gly-Leu-Gly(697) 
Asp-Glu-Ala-Gly-Thr-Gly(699) 
Asp-Glu-Ala-Gly-Thr-Ala(713) 
*Asp-Glu-Ala-Ala-Val-Gly(697) 
Asp-Glu-Ala-Ala-Ser-Gly(699) 
Asp-Glu-Ala- Ala-Ser-Ala (7 13) 
Possible sequences from peptide mixture Ib 
AZa( 134) 
Ala-Plo(231) 
Asp(195) 
Asp-Asn(360) 
Asp-GIu(358) 
Asp-Phe(359) 
Met(194) 
Met-Asn(359) 
Met-Phe(358) 
Ala-PTo-Leu(361) 
Ala-Pro-Leu-Asn(526) 
Ala-Pro-Leu-Glu(524) 
Ala-Pro-Leu-Phe(525) 
Asp-Asn-Asn(525) 
Asp-Asn-Phe(524) 
Asp-Glu-AIa(446) 
Asp-Phe-Asn(524) 
Met-Asn-Asn(524) 
Met-Phe-Ala(446) 
Asp-Asn-Asn-Val(641) 
Asp-Asn-Phe-Val(640) 
Asp-Asn-Phe-Tyr(721) 
Asp-Glu-Ala-Asp(595) 
Asp-Glu-Ala-Orn(639) 
Asp-Glu-Ala-Tyr(643) 
Asp-Phe-Asn-Val(640) 
Asp-Phe-Asn-Tyr(721) 
Met-Asn-Asn-Val(640) 
Met-Asn-Asn-Tyr(721) 
Met-Phe-Ala- Orn(639) 
Met-Phe-Ala-Tyr(643) 
Ala-Pro-Leu-Asn-Val(642) 
Ala-Pro-Leu-Asn-Asp(675) 
Ala-Pro-Leu-Glu-Vr.l(640) 
Ala-Pro-Leu-Glu-Tyr(721) 
Ala-Pro-Leu-Phe- Val(641) 
Ala-Pro-Leu-Asn-Val-Gly(716) 
Ala-Pro-Leu-Asn-Asp-Gly(749) 
Ala-Pro-Leu-Phe-Val -Gly(715) 
Asp-Asn-Asn-Val-Gly(7 13) 
Asp-Glu-Ala-Asp-Pro (692) 
Asp-Glu-Ala-Asp-Ser (716) 
The sequences common for the two derivatives are in italic. * See text. For the simplicity the 
sequences are indicated non-derivatized. The m/e of the peaks corresponding to the shown 
sequences are indicated in parenthesis. 
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Table 3 
Possible sequences after comparison of the results from the two 
derivatives of peptide mixture II. 
- --___ 
GlY Leu 
Gly-Pro Leu- Val 
Gly-Pro-Ala Leu-Val-Glu 
Gly-Pro-Ala-Thr Leu-Val-Glu-Ala 
Gly-Pro-Ala-Asp Leu-Val-Glu-Ser 
Gly-Pro-Ala-Met 
-~- ____~ 
For the simplicity the sequences are indicated non-derivatized. 
Asp and Gly-Pro-Ala-Met. Compensation for the 
’ 3C contribution from Leu-Val-Glu to the peak at 
m/e 441 in the spectrum of peptide mixture IIa 
eliminates Gly-Pro-Ala-Met . 
Gly-Pro-Ala-Asp cannot be eliminated by pure 
mass spectrometrical considerations. The probability 
for the existence of this sequence must, however, be 
considered very slight as the peaks on which it is based 
only slightly exceed the threshold level and as no 
termination or continuation was found. 
4. Discussion 
The possible sequences of peptide mixture Ia (table 
2) marked with an asterix or in italics are all deduced 
from the real sequence peaks thus demonstrating the 
insufficient information obtainable by mass spectro- 
metry of a single derivative. In several cases the listed 
hexapeptide sequences are terminated with Val-Gly. 
Due to alternatives listed in table 1, group A, the 
corresponding pentapeptide sequences with C-terminal 
ornithine are also deduced. The sequence peaks of 
Asp-Glu-Ala and Ala-Pro-Leu-Phe imply an alter- 
native sequence, Asp-Glu-Ala-Ala, which is of the 
type listed in D. This latter sequence results in 
Asp-Glu-Gln (type A). The sequence peaks of 
Ala-Pro-Leu-Phe-Val and Asp-Gh-Ala imply the 
alternative sequence Asp-Glu-Ala-Lys (type D). This 
sequence could also be deduced from Asp-Glu-Ala- 
Ala-Val (type A). 
In peptide mixture IIa the presence of Gly-Pro- 
Ala-Thr leads to an alternative sequence of type C, 
Gly-Pro-Try. In peptide mixture IIb Leu-V&Met 
is an alternative sequence of type D obtained by 
combination of the sequence peaks of Gly-Pro-Ala- 
‘Ihr and Leu-Val. 
It is observed that all the alternative sequences of 
type A, C and D can be eliminated by a comparison of 
the results obtained with the 2 derivatives. Further- 
more, all the alternative sequences due to non- 
sequence peaks in the mass spectra of peptide mixture 
I are eliminated and most of them deduced from the 
mass spectra of peptide mixture II. From table 2 it is 
seen that most of the alternative sequences due to non- 
sequence peaks are based upon the peaks on each side 
of the sequence peaks. Although these peaks normally 
are not considered by the interpretation of mass spectra 
of single peptides, they must be taken into account 
when dealing with peptide mixtures. 
The experiments here described thus demonstrate 
that the interpretation of mass spectra of peptide 
mixtures may be improved by carrying out the meas- 
urements on two different derivatives. 
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